COMP <GO>
NEU vs EMN // ALTMAN Z-SCORE & DEBT/EQUITY
NewMarket Corp (NYSE) VS. Eastman Chemical Company (NYSE) • 15-METRIC TALLY: NEU 7
— EMN 6
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: NEU
LAST: $783.66 (-2.42%) • MKT CAP: $7.39B
balance-sheet
4.77
LAST: $66.53 (-2.06%) • MKT CAP: $7.77B
balance-sheet
2.28
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NEU VS. EMN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NEU | EMN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 31.50% | 21.10% | +10.40 | NEU | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.60% | 4.80% | +11.80 | NEU | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.4x | 10.9x | +2.50 | EMN | /valuation <GO> |
| Free Cash Flow Yield | 6.65% | 5.46% | +1.19 | NEU | /fcf-yield <GO> |
| Operating Margin | 20.00% | 6.60% | +13.40 | NEU | /operating-margins <GO> |
| Net Profit Margin | 15.40% | 5.40% | +10.00 | NEU | /net-margins <GO> |
| Revenue Growth (YoY) | -2.20% | -6.70% | +4.50 | NEU | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.43% | 4.90% | -3.47 | EMN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 4.77 | 2.28 | +2.49 | NEU | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 28.4 | 60.3 | -31.90 | EMN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.96 | 1.06 | -0.10 | EMN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 16.4x | 15.3x | +1.10 | EMN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.39B | $7.77B | -$384.3M | EMN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NEU REV | EMN REV | NEU GROSS % | EMN GROSS % | NEU FCF | EMN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.73B | $8.75B | 31.5% | 21.1% | $491.3M | $424.0M |
| FY 2024 | $2.79B | $9.38B | 31.8% | 24.4% | $462.3M | $688.0M |
| FY 2023 | $2.70B | $9.21B | — | — | $455.4M | $959.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NEU // BETA 0.96
EMN // BETA 1.06